Lynn Morris to Alanine Transaminase
                            
                            
                                This is a "connection" page, showing publications Lynn Morris has written about Alanine Transaminase.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0,024
         
        
        
     
 
    
        
        - 
            Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial. Lancet Infect Dis. 2012 Jul; 12(7):521-30.
            
            
                Score: 0,024